Single-pill treatment proves as effective at suppressing virus as multi-pill therapy, while long-acting preventive injections are increasingly available ...
As the 2026 Conference on Retroviruses and Opportunistic Infections (CROI) wrapped up, leading HIV experts reflected on the ...
In patients with HIV‑1 infection and virologic suppression, switching to an investigational regimen of doravirine plus ...
Peak anti-hepatitis B surface antibody levels predicted increased viral protection in HIV, a French study shows.
For people living with human immunodeficiency virus (HIV), life-saving antiretroviral therapy keeps their HIV-infected immune cells from making new copies of the virus, preventing illness and ...
People with HIV (PWH) had a significantly higher risk of developing long COVID across multiple organ systems than people without HIV (PWoH), according to a large cohort study published in the Journal ...
Vaccine development remains central to reducing incident HIV globally, particularly where long-acting PrEP access is limited, with therapeutic and preventive approaches advancing in parallel.
Sexually transmitted diseases or STDs (formerly called venereal diseases) are among the world's most common infectious diseases. These bacterial or viral diseases are spread through sexual contact.